Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:34 PM
Ignite Modification Date:
2025-12-24 @ 2:34 PM
NCT ID:
NCT05320159
Eligibility Criteria:
Inclusion Criteria:
* ≥1 orders/administrations for secukinumab within the index window (March 1, 2018 to August 31,2019 for the base analysis; March 1, 2018 to January 31, 2020 for the refresh analysis). The date of the first order or administration was be the index date
* Patients in the MMDS database with a diagnosis of PsO on or prior to the 1st secukinumab order/administration
* ≥18 years of age as of the index date
* To ensure capturing continuous patient activities in the EMR dataset, patients must have at least one more visit (any visit regardless of diagnosis) in addition to the index visit within the first 6 months after secukinumab initiation
* Patients must have at least one visit (any visit regardless of diagnosis) within the 12 months pre-index period
Exclusion Criteria:
* Evidence of secukinumab use in the 12-month pre-index period
* Data quality issues (missing age, gender, prescription order information)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT05320159
Study Brief:
Protocol Section:
NCT05320159